228 related articles for article (PubMed ID: 25999473)
1. CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain.
Vingtdeux V; Chandakkar P; Zhao H; Blanc L; Ruiz S; Marambaud P
J Cell Sci; 2015 Jul; 128(13):2330-8. PubMed ID: 25999473
[TBL] [Abstract][Full Text] [Related]
2. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
[TBL] [Abstract][Full Text] [Related]
3. CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β.
Moreno-Ortega AJ; Buendia I; Mouhid L; Egea J; Lucea S; Ruiz-Nuño A; López MG; Cano-Abad MF
Aging Cell; 2015 Dec; 14(6):1094-102. PubMed ID: 26416646
[TBL] [Abstract][Full Text] [Related]
4. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
[TBL] [Abstract][Full Text] [Related]
6. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
[TBL] [Abstract][Full Text] [Related]
7. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer's disease.
Del Campo M; Stargardt A; Veerhuis R; Reits E; Teunissen CE
Neurosci Lett; 2015 Mar; 589():47-51. PubMed ID: 25597881
[TBL] [Abstract][Full Text] [Related]
9. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
[TBL] [Abstract][Full Text] [Related]
10. Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.
Tamboli IY; Barth E; Christian L; Siepmann M; Kumar S; Singh S; Tolksdorf K; Heneka MT; Lütjohann D; Wunderlich P; Walter J
J Biol Chem; 2010 Nov; 285(48):37405-14. PubMed ID: 20876579
[TBL] [Abstract][Full Text] [Related]
11. Powering Amyloid Beta Degrading Enzymes: A Possible Therapy for Alzheimer's Disease.
Sikanyika NL; Parkington HC; Smith AI; Kuruppu S
Neurochem Res; 2019 Jun; 44(6):1289-1296. PubMed ID: 30806879
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
Dreses-Werringloer U; Lambert JC; Vingtdeux V; Zhao H; Vais H; Siebert A; Jain A; Koppel J; Rovelet-Lecrux A; Hannequin D; Pasquier F; Galimberti D; Scarpini E; Mann D; Lendon C; Campion D; Amouyel P; Davies P; Foskett JK; Campagne F; Marambaud P
Cell; 2008 Jun; 133(7):1149-61. PubMed ID: 18585350
[TBL] [Abstract][Full Text] [Related]
13. Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer's Disease.
Li G; Kim C; Kim J; Yoon H; Zhou H; Kim J
J Alzheimers Dis; 2015; 46(1):109-22. PubMed ID: 25720399
[TBL] [Abstract][Full Text] [Related]
14. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo.
Miller BC; Eckman EA; Sambamurti K; Dobbs N; Chow KM; Eckman CB; Hersh LB; Thiele DL
Proc Natl Acad Sci U S A; 2003 May; 100(10):6221-6. PubMed ID: 12732730
[TBL] [Abstract][Full Text] [Related]
16. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
Farris W; Mansourian S; Leissring MA; Eckman EA; Bertram L; Eckman CB; Tanzi RE; Selkoe DJ
Am J Pathol; 2004 Apr; 164(4):1425-34. PubMed ID: 15039230
[TBL] [Abstract][Full Text] [Related]
17. Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease.
Jaya Prasanthi RP; Schommer E; Thomasson S; Thompson A; Feist G; Ghribi O
Mech Ageing Dev; 2008 Nov; 129(11):649-55. PubMed ID: 18845178
[TBL] [Abstract][Full Text] [Related]
18. Effect of the CALHM1 G330D and R154H human variants on the control of cytosolic Ca2+ and Aβ levels.
Vingtdeux V; Tanis JE; Chandakkar P; Zhao H; Dreses-Werringloer U; Campagne F; Foskett JK; Marambaud P
PLoS One; 2014; 9(11):e112484. PubMed ID: 25386646
[TBL] [Abstract][Full Text] [Related]
19. CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.
Dreses-Werringloer U; Vingtdeux V; Zhao H; Chandakkar P; Davies P; Marambaud P
J Cell Sci; 2013 Mar; 126(Pt 5):1199-206. PubMed ID: 23345406
[TBL] [Abstract][Full Text] [Related]
20. Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy.
Morelli L; Llovera RE; Mathov I; Lue LF; Frangione B; Ghiso J; Castaño EM
J Biol Chem; 2004 Dec; 279(53):56004-13. PubMed ID: 15489232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
